Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07264504
Recruiting Not applicable

Experimentation of Formaldehyde Purification by Plants in the Anatomy and Cytology Department

NCT07264504 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Not applicable
Started
2024-09-25
Last updated
2025-12-04

Condition(s) studied

FormaldehydePathological Anatomy and Cytology

Investigational drug(s) / intervention(s)

Biological measurement of urinary formic acidPlant installation

Biological measurement of urinary formic acid: Biological measurement of urinary formic acid

Plant installation: plant installation

Study summary

Formaldehyde is notably used as a tissue fixator in pathological anatomy. Despite its toxicity, it continues to be widely used because it is currently not substitutable. Some plants have shown their ability to absorb formaldehyde. The investigators would like to show if the installation of plants in the Anatomy and Cytology Department of the Amiens University Hospital reduces the exposure to formaldehyde of the staff of this department. After carrying out atmospheric and biological measurements the investigators will install 15 plants in both rooms where the staff is most exposed to formaldehyde : the macroscopy room and the reception room. The atmospheric and biological measurements will be redone after two months.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * To work in the Department of Pathological Anatomy and Cytology * Adult (\> 18 years old) * Patient information and collection of non-opposition Exclusion Criteria: * Pregnant woman * Patients under guardianship or safeguarding of justice

Primary outcome measure(s)

  • Atmospheric formaldehyde concentration — 2 months
    Variation of Atmospheric measurement of formaldehyde between before and after plant installation

Trial sites (1)

FacilityCityRegionStatus
CHRU Amiens Amiens France Recruiting

More Centre Hospitalier Universitaire, Amiens trials in France

Study of the Link Between Structural Alterations in the Hypothalamus and Cardiac Dysautonomia in Drug-resistant Epilepsy Recruiting
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD Recruiting
Is Cap Assisted Endoscopy Useful in Acute Upper Gastrointestinal Bleeding ? Recruiting
Salivary Replication of BK Virus in Post-kidney Transplant Starting soon
Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock? Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07264504 on ClinicalTrials.gov ↗ ← All trials in France